Paid Clinical Trials New York State
Discover 4,179 paid clinical trials in New York State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Beta BlockerCSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
Sponsor:
VA Office of Research and Development
Location:
Code:
NCT05931276
Conditions
End-Stage Kidney Disease
End-Stage Renal Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Metoprolol Succinate
Carvedilol
Lomustine with Temozolomide & RadiationTesting the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
Sponsor:
NRG Oncology
Location:
Code:
NCT05095376
Conditions
Glioblastoma
Gliosarcoma
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
Lomustine
Magnetic Resonance Imaging
Photon Beam Radiation Therapy
Questionnaire Administration
Temozolomide
Mezigdomide & CarfilzomibA Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)
Sponsor:
Bristol-Myers Squibb
Location:
Code:
NCT05552976
Conditions
Relapsed or Refractory Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Mezigdomide
Carfilzomib
Dexamethasone
CLN-619 & PembrolizumabA Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors
Sponsor:
Cullinan Therapeutics Inc.
Location:
Code:
NCT05117476
Conditions
Advanced Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CLN-619
Pembrolizumab
Blood Pressure ControlA Study of Blood Pressure Control During Cancer Treatment
Sponsor:
Memorial Sloan Kettering Cancer Center
Location:
Code:
NCT06023576
Conditions
Breast Cancer
Cardiotoxicity
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
antihypertensive medications
Blood pressure measurement
Echocardiogram
Symptom-limited cardiopulmonary exercise test
Quality of Life Measures
AMT-162Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)
Sponsor:
UniQure Biopharma B.V.
Location:
Code:
NCT06100276
Conditions
Amyotrophic Lateral Sclerosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AMT-162
CenerimodA Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus
Sponsor:
Idorsia Pharmaceuticals Ltd.
Location:
Code:
NCT05672576
Conditions
Lupus Erythematosus, Systemic
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Cenerimod
Placebo
AtogepantA Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Sponsor:
AbbVie
Location:
Code:
NCT05711394
Conditions
Episodic Migraine
Eligibility Criteria
Sex: All
Age: 6 - 17
Healthy Volunteers: Not accepted
Interventions
Atogepant
Placebo-Matching Atogepant
Optimizing TreatmentOptimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach
Sponsor:
HELP for NOWS Consortium
Location:
Code:
NCT05980260
Conditions
Neonatal Opiate Withdrawal Syndrome
Eligibility Criteria
Sex: All
Age: 1 - 48
Healthy Volunteers: Not accepted
Interventions
Symptom-based Dosing Approach
Scheduled Opioid Taper Approach
LuspaterceptA Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Sponsor:
Celgene
Location:
Code:
NCT04064060
Conditions
Myelodysplastic Syndromes (MDS)
Beta-thalassemia
Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Luspatercept